Thryve Peptides
BPC-157 (5mg) + TB500 (5mg) Combo
BPC-157 (5mg) + TB500 (5mg) Combo
Couldn't load pickup availability
BPC-157 / TB500 (10MG Total)
Dual-action peptide system — crafted for precision research and reproducibility.
- Contains equal proportions of BPC-157 (5mg) and TB-500 (5mg) for a combined 10 mg total.
- Formulated for controlled investigations of angiogenesis, actin regulation, and cell migration models.
- Independently verified by Vanguard Laboratory for purity and identity assurance.
For laboratory research use only. Not for human consumption.
Scientific Evidence
BPC-157 is a 15-amino-acid peptide isolated from gastric proteins and studied for its potential roles in endothelial stability and angiogenic signaling through VEGFR2 / Akt / eNOS pathways (PubMed 30674691).
TB-500 (Thymosin-β4 analog) is a 43-amino-acid actin-binding peptide investigated for cell migration, angiogenesis, and tissue remodeling in both dermal and cardiac models (Front Endocrinol 2018).
Combined use of these peptides has been researched for potential synergistic effects on vascular regeneration and soft-tissue repair (PubMed 23891802).
Regulatory Status: BPC-157 and TB-500 are not FDA-approved for human or veterinary use and are supplied strictly for research applications.
